Showing results (191-200 of 223) with videos related to
Sort By:
Pageof 23
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.Journal of Neurology|September 7, 2021
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEMJuan I Rojas, Agustín Pappolla, Patricio Blaya, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.Nature Reviews. Neurology|July 15, 2022
From the prodromal stage of multiple sclerosis to disease preventionRuth Ann Marrie, Mark Allegretta, Lisa F Barcellos, et al.Journal of the Neurological Sciences|October 19, 2025
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world studyMaría Agustina Piedrabuena, Jorge Correale, Berenice Silva, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 19, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registryEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.Journal of Neurology|April 17, 2024
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settingsClaudia Pestchanker, Brenda Bertado Cortez, Marco A Lana Peixoto, et al.Pageof 23